Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 559

1.

'Doctor, why is my baby's arm black?' The neonatal presentation of a Giant Congenital Melanocytic Naevus.

Parmenter KF, Lok A.

Postgrad Med J. 2019 Jun 13. pii: postgradmedj-2019-136629. doi: 10.1136/postgradmedj-2019-136629. [Epub ahead of print] No abstract available.

PMID:
31196887
2.

Patient-reported symptoms during and after direct acting antiviral therapies for chronic hepatitis C: The PROP UP Study.

Evon DM, Sarkar S, Amador J, Lok AS, Sterling RK, Stewart PW, Reeve BB, Serper M, Reau N, Rajender Reddy K, Di Bisceglie AM, Nelson DR, Golin CE, Lim JK, Fried MW.

J Hepatol. 2019 May 13. pii: S0168-8278(19)30278-8. doi: 10.1016/j.jhep.2019.04.016. [Epub ahead of print]

PMID:
31096006
3.

The Quality and Outcomes of Care Provided to Patients with Cirrhosis by Advanced Practice Providers.

Tapper EB, Hao S, Lin M, Mafi JN, McCurdy H, Parikh ND, Lok AS.

Hepatology. 2019 May 7. doi: 10.1002/hep.30695. [Epub ahead of print]

PMID:
31063262
4.

FLT3 ligand plasma levels have no impact on outcomes after allotransplant in acute leukemia.

Peterlin P, Gaschet J, Guillaume T, Garnier A, Eveillard M, Le Bourgeois A, Cherel M, Debord C, Le Bris Y, Theisen O, Mahé B, Dubruille V, Godon C, Robillard N, Wuilleme S, Touzeau C, Gastinne T, Blin N, Lok A, Bonnet A, Le Gouill S, Moreau P, Béné MC, Chevallier P.

Cytokine. 2019 Aug;120:85-87. doi: 10.1016/j.cyto.2019.04.015. Epub 2019 Apr 28.

PMID:
31035172
5.

[Reaction on 'Persistant underuse of ECT for persistant depressive disorder?']

Scheepens DS, van Waarde JA, Lok A, Zantvoord JB, de Pont BJHB, Ruhé HG, Denys DAJP, van Wingen GA.

Tijdschr Psychiatr. 2019;61(4):287. Dutch.

6.

Update of the statements on biology and clinical impact of occult hepatitis b virus infection.

Raimondo G, Locarnini S, Pollicino T, Levrero M, Zoulim F, Lok AS; Taormina Workshop on Occult HBV Infection Faculty Members.

J Hepatol. 2019 Apr 17. pii: S0168-8278(19)30259-4. doi: 10.1016/j.jhep.2019.03.034. [Epub ahead of print] Review.

7.

Distinct phenotype and function of circulating Vδ1+ and Vδ2+ γδT-cells in acute and chronic hepatitis B.

Chang KM, Traum D, Park JJ, Ho S, Ojiro K, Wong DK, Wahed AS, Terrault NA, Khalili M, Sterling RK, Janssen HLA, Shuhart MC, Lau DT, Roberts LR, Johnson GS, Kaplan DE, Betts MR, Lee WM, Lok ASF; Hepatitis B Research Network (HBRN).

PLoS Pathog. 2019 Apr 18;15(4):e1007715. doi: 10.1371/journal.ppat.1007715. eCollection 2019 Apr.

8.

Erratum: Design and rationale of a randomized-controlled trial of home-delivered meals for the management of symptomatic ascites: the SALTYFOOD trial.

Tapper EB, Baki J, Hummel S, Lok A.

Gastroenterol Rep (Oxf). 2019 Apr;7(2):150. doi: 10.1093/gastro/goz017. Epub 2019 Apr 13.

9.

Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.

Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB.

Clin Liver Dis (Hoboken). 2018 Aug 22;12(1):33-34. doi: 10.1002/cld.728. eCollection 2018 Jul. Review. No abstract available.

10.

Design and rationale of a randomized-controlled trial of home-delivered meals for the management of symptomatic ascites: the SALTYFOOD trial.

Tapper EB, Baki J, Hummel S, Lok A.

Gastroenterol Rep (Oxf). 2019 Apr;7(2):146-149. doi: 10.1093/gastro/goz005. Epub 2019 Mar 11. Erratum in: Gastroenterol Rep (Oxf). 2019 Apr;7(2):150.

11.

Management of acute musculoskeletal pain (excluding low back pain): protocol for a systematic review and network meta-analysis of randomised trials.

Busse JW, Craigie S, Sadeghirad B, Couban R, Hong P, Oparin Y, May C, Lok A, Guyatt GH.

BMJ Open. 2019 Apr 3;9(4):e024441. doi: 10.1136/bmjopen-2018-024441.

12.

Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies.

Bouard L, Guillaume T, Peterlin P, Garnier A, Le Bourgeois A, Duquenne A, Mahe B, Dubruille V, Blin N, Touzeau C, Gastinne T, Le Bris Y, Lok A, Bonnet A, Le Gouill S, Moreau P, Bene MC, Chevallier P.

Biol Blood Marrow Transplant. 2019 Mar 27. pii: S1083-8791(19)30209-5. doi: 10.1016/j.bbmt.2019.03.025. [Epub ahead of print]

PMID:
30928627
13.

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study.

Trudel S, Tessoulin B, Jullien M, Blin N, Gastinne T, Mahé B, Dubruille V, Bonnet A, Lok A, Chevallier P, Peterlin P, Garnier A, Guillaume T, Le Bourgeois A, Le Gouill S, Moreau P, Touzeau C.

Ann Hematol. 2019 Jun;98(6):1441-1447. doi: 10.1007/s00277-019-03649-3. Epub 2019 Mar 14.

PMID:
30874851
14.

Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study.

Jullien M, Trudel S, Tessoulin B, Mahé B, Dubruille V, Blin N, Gastinne T, Bonnet A, Lok A, Lebourgeois A, Peterlin P, Garnier A, Chevalier P, Guillaume T, Thomaré P, Le Gouill S, Moreau P, Touzeau C.

Ann Hematol. 2019 Jun;98(6):1435-1440. doi: 10.1007/s00277-019-03655-5. Epub 2019 Mar 14.

PMID:
30874850
15.

Reply.

Lok AS, Powderly WG.

Hepatology. 2019 May;69(5):2301. doi: 10.1002/hep.30564.

PMID:
30762891
16.

Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.

Brahmania M, Lombardero M, Hansen BE, Terrault NA, Lok AS, Perrillo RP, Belle SH, Di Bisceglie AM, Feld JJ, Lee WM, Fried MW, Janssen HLA; Hepatitis B Research Network.

Clin Gastroenterol Hepatol. 2019 Feb 8. pii: S1542-3565(19)30143-0. doi: 10.1016/j.cgh.2019.02.005. [Epub ahead of print]

PMID:
30743006
17.

Gender Disparities in Alcohol Use Disorder Treatment Among Privately Insured Patients with Alcohol-Associated Cirrhosis.

Mellinger JL, Fernandez A, Shedden K, Winder GS, Fontana RJ, Volk ML, Blow FC, Lok ASF.

Alcohol Clin Exp Res. 2019 Feb;43(2):334-341. doi: 10.1111/acer.13944. Epub 2019 Jan 22.

PMID:
30667521
18.

[Electroconvulsion therapy for persistent depression in the Netherlands; very low application rate].

Scheepens DS, van Waarde JA, Lok A, Zantvoord JB, de Pont BJHB, Ruhé HG, Denys DAJP, van Wingen GA.

Tijdschr Psychiatr. 2019;61(1):16-21. Dutch.

19.

Testing Pediatric Acuity With an iPad: Validation of "Peekaboo Vision" in Malawi and the UK.

Livingstone I, Butler L, Misanjo E, Lok A, Middleton D, Wilson JW, Delfin S, Kayange P, Hamilton R.

Transl Vis Sci Technol. 2018 Jan 9;8(1):8. doi: 10.1167/tvst.8.1.8. eCollection 2019 Jan.

20.

FLT3 ligand plasma levels in acute myeloid leukemia.

Peterlin P, Gaschet J, Guillaume T, Garnier A, Eveillard M, Le Bourgeois A, Cherel M, Debord C, Le Bris Y, Theisen O, Mahé B, Dubruille V, Godon C, Robillard N, Wuilleme S, Touzeau C, Gastinne T, Blin N, Lok A, Bonnet A, Le Gouill S, Moreau P, Béné MC, Chevallier P.

Haematologica. 2019 Jun;104(6):e240-e243. doi: 10.3324/haematol.2018.209460. Epub 2019 Jan 10. No abstract available.

21.

[Proper patient education improves hepatitis C patients' disease-related knowledge and antiviral treatment acceptance in rural China].

Yang M, Rao HY, Feng B, Wu E, Wei L, Lok AS.

Zhonghua Gan Zang Bing Za Zhi. 2018 Nov 20;26(11):824-828. doi: 10.3760/cma.j.issn.1007-3418.2018.11.004. Chinese.

PMID:
30616316
22.

Frequency and Outcomes of Abnormal Imaging in Patients With Cirrhosis Enrolled in a Hepatocellular Carcinoma Surveillance Program.

Konerman MA, Verma A, Zhao B, Singal AG, Lok AS, Parikh ND.

Liver Transpl. 2019 Mar;25(3):369-379. doi: 10.1002/lt.25398.

PMID:
30582779
23.

The Use and Effects of Electronic Health Tools for Patient Self-Monitoring and Reporting of Outcomes Following Medication Use: Systematic Review.

Lancaster K, Abuzour A, Khaira M, Mathers A, Chan A, Bui V, Lok A, Thabane L, Dolovich L.

J Med Internet Res. 2018 Dec 18;20(12):e294. doi: 10.2196/jmir.9284. Review.

24.

Impact of a structured lifestyle programme on patients with metabolic syndrome complicated by non-alcoholic fatty liver disease.

Konerman MA, Walden P, Joseph M, Jackson EA, Lok AS, Rubenfire M.

Aliment Pharmacol Ther. 2019 Feb;49(3):296-307. doi: 10.1111/apt.15063. Epub 2018 Dec 18.

PMID:
30561027
25.

Nonparametric Maximum Likelihood Estimators of Time-Dependent Accuracy Measures for Survival Outcome Under Two-Stage Sampling Designs.

Liu D, Cai T, Lok A, Zheng Y.

J Am Stat Assoc. 2018;113(522):882-892. doi: 10.1080/01621459.2017.1295866. Epub 2017 Feb 28.

26.

Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection.

Feld JJ, Terrault NA, Lin HS, Belle SH, Chung RT, Tsai N, Khalili M, Perrillo R, Cooper SL, Ghany MG, Janssen HLA, Lok AS; Hepatitis B Research Network.

Hepatology. 2019 Jun;69(6):2338-2348. doi: 10.1002/hep.30417. Epub 2019 Mar 14.

PMID:
30549279
27.

p53 regulates CD46 expression and measles virus infection in myeloma cells.

Lok A, Descamps G, Tessoulin B, Chiron D, Eveillard M, Godon C, Le Bris Y, Vabret A, Bellanger C, Maillet L, Barillé-Nion S, Gregoire M, Fonteneau JF, Le Gouill S, Moreau P, Tangy F, Amiot M, Moreau-Aubry A, Pellat-Deceunynck C.

Blood Adv. 2018 Dec 11;2(23):3492-3505. doi: 10.1182/bloodadvances.2018025106.

28.

Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Office Employees in Beijing, China.

Zhang W, Chao S, Chen S, Rao H, Huang R, Wei L, Lok AS.

Dig Dis Sci. 2019 Mar;64(3):708-717. doi: 10.1007/s10620-018-5389-5. Epub 2018 Nov 27.

PMID:
30483909
29.

Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients.

Bouard L, Bodet-Milin C, Bailly C, Guillaume T, Peterlin P, Garnier A, Bourgeois AL, Mahé B, Dubruille V, Blin N, Touzeau C, Gastinne T, Lok A, Bonnet A, Béné MC, Gouill SL, Moreau P, Kraeber-Bodéré F, Chevallier P.

Biol Blood Marrow Transplant. 2019 May;25(5):906-911. doi: 10.1016/j.bbmt.2018.11.019. Epub 2018 Nov 24.

PMID:
30481598
30.

Cortisol, dehydroepiandrosterone sulfate, fatty acids, and their relation in recurrent depression.

Ter Horst DM, Schene AH, Figueroa CA, Assies J, Lok A, Bockting CLH, Ruhé HG, Mocking RJT.

Psychoneuroendocrinology. 2019 Feb;100:203-212. doi: 10.1016/j.psyneuen.2018.10.012. Epub 2018 Oct 19.

PMID:
30388594
31.

Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated With Poor Patient-Reported Outcomes in Cirrhosis.

Tapper EB, Baki J, Parikh ND, Lok AS.

Hepatology. 2019 Apr;69(4):1676-1685. doi: 10.1002/hep.30336. Epub 2019 Feb 19.

PMID:
30382584
32.

Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis.

Yeo YH, Ho HJ, Yang HI, Tseng TC, Hosaka T, Trinh HN, Kwak MS, Park YM, Fung JYY, Buti M, Rodríguez M, Treeprasertsuk S, Preda CM, Ungtrakul T, Charatcharoenwitthaya P, Li X, Li J, Zhang J, Le MH, Wei B, Zou B, Le A, Jeong D, Chien N, Kam L, Lee CC, Riveiro-Barciela M, Istratescu D, Sriprayoon T, Chong Y, Tanwandee T, Kobayashi M, Suzuki F, Yuen MF, Lee HS, Kao JH, Lok AS, Wu CY, Nguyen MH.

Gastroenterology. 2019 Feb;156(3):635-646.e9. doi: 10.1053/j.gastro.2018.10.027. Epub 2018 Oct 17.

PMID:
30342034
33.

Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignancies.

Chevallier P, Peterlin P, Garnier A, Le Bourgeois A, Mahé B, Dubruille V, Blin N, Touzeau C, Gastinne T, Lok A, Le Bris Y, Béné MC, Le Gouill S, Moreau P, Guillaume T.

Oncotarget. 2018 Sep 11;9(71):33528-33535. doi: 10.18632/oncotarget.26083. eCollection 2018 Sep 11.

34.

Passive transfer of anti-HBc after intravenous immunoglobulin administration in patients with cancer: a retrospective chart review.

Lu H, Lok AS, Warneke CL, Ahmed S, Torres HA, Martinez F, Suarez-Almazor ME, Foreman JT, Ferrajoli A, Hwang JP.

Lancet Haematol. 2018 Oct;5(10):e474-e478. doi: 10.1016/S2352-3026(18)30152-2.

PMID:
30290904
35.

A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study.

Lee HM, Ahn J, Kim WR, Lim JK, Nguyen M, Pan CQ, Kim D, Mannalithara A, Te H, Trinh H, Chu D, Tran T, Woog J, Lok AS.

Dig Dis Sci. 2019 Feb;64(2):358-366. doi: 10.1007/s10620-018-5281-3. Epub 2018 Sep 20.

PMID:
30238203
36.

Reply.

Terrault NA, Brown RS Jr, Lok AS, Wong JB, Bzowej NH, Chang KM, Hwang JP, Jonas MM, McMahon BJ.

Hepatology. 2018 Oct;68(4):1658-1660. doi: 10.1002/hep.30137. No abstract available.

PMID:
30070717
37.

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study.

Evon DM, Stewart PW, Amador J, Serper M, Lok AS, Sterling RK, Sarkar S, Golin CE, Reeve BB, Nelson DR, Reau N, Lim JK, Reddy KR, Di Bisceglie AM, Fried MW.

PLoS One. 2018 Aug 1;13(8):e0196908. doi: 10.1371/journal.pone.0196908. eCollection 2018.

38.

Evaluating longitudinal markers under two-phase study designs.

Maziarz M, Cai T, Qi L, Lok AS, Zheng Y.

Biostatistics. 2018 Apr 18. doi: 10.1093/biostatistics/kxy013. [Epub ahead of print]

PMID:
29912281
39.

Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis.

Mellinger JL, Scott Winder G, DeJonckheere M, Fontana RJ, Volk ML, Lok ASF, Blow FC.

J Subst Abuse Treat. 2018 Aug;91:20-27. doi: 10.1016/j.jsat.2018.05.003. Epub 2018 May 18.

PMID:
29910011
40.

Tenofovir to Prevent Perinatal Transmission of Hepatitis B.

Terrault NA, Feld JJ, Lok ASF.

N Engl J Med. 2018 Jun 14;378(24):2348-9. doi: 10.1056/NEJMc1805396. No abstract available.

PMID:
29900725
41.

Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases.

Peterlin P, Guillaume T, Garnier A, Le Bourgeois A, Mahé B, Dubruille V, Blin N, Gallas P, Touzeau C, Gastinne T, Lok A, Thomare P, Chauvin C, Le Gouill S, Moreau P, Chevallier P.

Leuk Res Rep. 2018 Jan 17;9:16-17. doi: 10.1016/j.lrr.2018.01.002. eCollection 2018. No abstract available.

42.

Optimizing medication management for patients with cirrhosis: Evidence-based strategies and their outcomes.

Thomson MJ, Lok AS, Tapper EB.

Liver Int. 2018 Nov;38(11):1882-1890. doi: 10.1111/liv.13892. Epub 2018 Jun 19. Review.

PMID:
29845749
43.

Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-term Treatment With Tumor Necrosis Factor Antagonists.

Pauly MP, Tucker LY, Szpakowski JL, Ready JB, Baer D, Hwang J, Lok AS.

Clin Gastroenterol Hepatol. 2018 Dec;16(12):1964-1973.e1. doi: 10.1016/j.cgh.2018.04.033. Epub 2018 Apr 24.

PMID:
29702293
44.

Treatment-resistant depression and suicidality.

Bergfeld IO, Mantione M, Figee M, Schuurman PR, Lok A, Denys D.

J Affect Disord. 2018 Aug 1;235:362-367. doi: 10.1016/j.jad.2018.04.016. Epub 2018 Apr 3. Review.

PMID:
29665520
45.

Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B.

Khalili M, Shuhart MC, Lombardero M, Feld JJ, Kleiner DE, Chung RT, Terrault NA, Lisker-Melman M, Sanyal A, Lok AS; Hepatitis B Research Network (HBRN); Harvard Consortium.

Diabetes Care. 2018 Jun;41(6):1251-1259. doi: 10.2337/dc18-0040. Epub 2018 Mar 29.

46.

The high burden of alcoholic cirrhosis in privately insured persons in the United States.

Mellinger JL, Shedden K, Winder GS, Tapper E, Adams M, Fontana RJ, Volk ML, Blow FC, Lok ASF.

Hepatology. 2018 Sep;68(3):872-882. doi: 10.1002/hep.29887. Epub 2018 May 20.

PMID:
29579356
47.

Diagnosis of Minimal Hepatic Encephalopathy: A Systematic Review of Point-of-Care Diagnostic Tests.

Tapper EB, Parikh ND, Waljee AK, Volk M, Carlozzi NE, Lok AS.

Am J Gastroenterol. 2018 Apr;113(4):529-538. doi: 10.1038/ajg.2018.6. Epub 2018 Mar 13. Review.

PMID:
29533396
48.

Dos and Don'ts in the Management of Cirrhosis: A View from the 21st Century.

Thomson MJ, Tapper EB, Lok ASF.

Am J Gastroenterol. 2018 Jul;113(7):927-931. doi: 10.1038/s41395-018-0028-5. Epub 2018 Mar 9. No abstract available.

49.

Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort Study.

Hwang JP, Lok AS, Fisch MJ, Cantor SB, Barbo A, Lin HY, Foreman JT, Vierling JM, Torres HA, Granwehr BP, Miller E, Eng C, Simon GR, Ahmed S, Ferrajoli A, Romaguera J, Suarez-Almazor ME.

J Clin Oncol. 2018 Feb 15:JCO2017756387. doi: 10.1200/JCO.2017.75.6387. [Epub ahead of print]

PMID:
29447061
50.

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB.

Hepatology. 2018 Apr;67(4):1560-1599. doi: 10.1002/hep.29800. No abstract available.

Supplemental Content

Support Center